Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Titel:
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Auteur:
Kapoor, Raju Ho, Pei-Ran Campbell, Nolan Chang, Ih Deykin, Aaron Forrestal, Fiona Lucas, Nisha Yu, Bei Arnold, Douglas L Freedman, Mark S Goldman, Myla D Hartung, Hans-Peter Havrdová, Eva Kubala Jeffery, Douglas Miller, Aaron Sellebjerg, Finn Cadavid, Diego Mikol, Dan Steiner, Deborah